Novartis Investigative Site

Piešťany, SVK 921 12

0 studies enrolling now · 2 studies all time

What they study most

Ankylosing Spondylitis, Spondylitis, Ankylosing

Studies at this site

• Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) — Completed
• 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis — Completed